Saturday 17 October 2026
Export HLTHQ’s income statement to Excel — free account
Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
0.00
0.00
NaN
Follow HLTHQ
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.50 | 0.32 | 0.22 | 0.84 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.22) | (5.02) | (1.32) | (5.10) | |
P/B ratio |
0.14 | 0.16 | 0.13 | 0.55 | |
Price to Tangible BV |
0.15 | 0.17 | 0.14 | 0.58 | |
EV/Sales |
(0.65) | (0.25) | (0.29) | 0.29 | |
EV/EBITDA |
0.14 | 0.21 | 0.31 | 0.00 | |
EV/Operating CF |
0.33 | 0.30 | 0.39 | (0.49) | |
EV/FCF |
0.29 | 0.26 | 0.32 | (0.38) | |
Quick Ratio |
1.91 | 1.94 | 2.30 | 2.80 | |
Current Ratio |
2.54 | 3.29 | 3.72 | 4.25 | |
Net Debt/EBITDA |
0.63 | 2.20 | 1.77 | 2.13 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.07% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.14 | 0.30 | 0.35 | 0.41 | |
Operating CF/Net income |
0.19 | 0.27 | 0.51 | 0.57 | |
Capex/Depreciation |
(0.10) | (0.27) | (0.48) | (0.69) | |
Interest Coverage |
(432.86) | (212.85) | (293.45) | (435.68) | |
Research and Development Expense of Revenue |
171.55% | 212.30% | 369.20% | 180.63% | |
Selling, General and Administrative Expense of Revenue |
85.60% | 131.02% | 230.01% | 113.81% | |
Intangible Assets out of Total Assets |
0.06 | 0.04 | 0.04 | 0.03 | |
Share Based Compensation of Revenue |
53.93% | 72.59% | 116.24% | 58.17% | |
Graham Net Nets |
0.59 | 1.41 | 1.98 | 0.63 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1,060.87%) | (412.20%) | (494.59%) | (107.14%) | |
Free Cash Flow Yield |
(448.24%) | (299.67%) | (410.76%) | (92.60%) | |
Revenue per Share |
0.12 | 0.11 | 0.07 | 0.16 | |
Operating CF per Share |
(0.19) | (0.08) | (0.28) | (0.36) | |
Capex per Share |
(0.01) | (0.02) | (0.04) | (0.06) | |
Free Cash Flow per Share |
(0.20) | (0.11) | (0.32) | (0.41) | |
Cash per Share |
0.53 | 0.73 | 0.85 | 1.18 | |
Shareholders Equity per Share |
1.64 | 2.53 | 2.79 | 3.28 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.64 | 2.53 | 2.79 | 3.28 | |
Free Cash Flow |
(30.55) | (16.20) | (48.65) | (62.20) | |
Working Capital |
66.90 | 133.83 | 155.05 | 219.54 | |
Capital Expenditures |
(1.83) | (3.66) | (5.99) | (8.32) | |
Net Current Asset Value |
20.83 | 88.78 | 111.39 | 174.30 | |
EV/EBIT |
0.12 | 0.17 | 0.25 | 0.00 | |
Capex to Sales |
0.10 | 0.21 | 0.61 | 0.34 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
10.05 | 13.05 | 27.86 | 42.81 | |
Average Payables |
7.43 | 21.82 | 24.78 | 32.74 | |
Average Inventory |
48.12 | 98.43 | 103.71 | 107.29 | |
Average Assets |
517.18 | 658.66 | 718.97 | 796.17 | |
Average Common Equity |
413.37 | 489.40 | 531.78 | 610.50 |
Columns are period end dates